People with type 2 diabetes often struggle with maintaining long-term glycemic control. Tirzepatide has shown consistent results in reducing HbA1c levels, with many patients achieving levels below 7%, which is the standard treatment goal. Some studies have even reported reductions greater than 2% in HbA1c. https://biotechlabzsupply.com/